
Medical Device Classification Rules
Without knowing your device's class, you can neither choose the conformity assessment route nor open the ÜTS registration in the right framework. Class
Medical Device Classification Rules: The 22 MDR Rules, the 7 IVDR Rules and ÜTS Class Selection
Without knowing your device's class, you can neither choose the conformity assessment route nor open the ÜTS registration in the right framework. Class is the first decision: it determines the type of certificate, whether a notified body becomes involved and the mandatory fields on the registration screen, and if it is determined wrongly it can only be corrected by a data change request approved by the Agency.
This page gives all 22 MDR and 7 IVDR classification rules, each with its criterion and resulting class, and then compares the 18 MDD rules with MDR. All provisions are taken from Articles 51 to 57 of TİTCK's "Guide on the Registration Processes of Medical Devices to the Product Tracking System" (TCKKD-KLVZ-03).
Classification Is Based on the Intended Purpose
The starting point of classification is not what the product is, but what it is used for. Paragraph 1 of Article 52 of the Guide puts it in a single sentence: the application of classification rules for all Medical Device Regulations is based on the intended purpose of the devices. The same product may fall into a different class when it is placed on the market with a different intended purpose.
The number and names of classes vary by framework. Paragraph 1 of Article 56 of the Guide states that devices under MDR are divided into four classes, Class I, Class IIa, Class IIb and Class III, according to the risks arising from their intended purpose and structure. Paragraph 1 of Article 57 states that devices under IVDR are divided on the same basis into four classes, Class A, Class B, Class C and Class D.
Medical Device Classification Wizard
To see the estimated class of your device before reading the rules one by one, you can use the wizard below. The wizard applies the Annex VIII rules through questions about the intended purpose; it shows the rule applied as a verbatim quotation from the regulation, whether a notified body is required and the basic documents to be linked to the device in ÜTS. The result is not binding; the final class is determined by the intended purpose defined by the manufacturer and the technical file.
Special Definitions Used in Classification
The rules are written not in everyday words but in terms defined by the Guide itself. Paragraph 1 of Article 51 of the Guide states that special definitions are used in the classification of devices, particularly under MDD and MDR; paragraph 2 lists these definitions.
Transient, Short-Term and Long-Term Use
Duration thresholds directly determine the class of invasive devices and are set out in paragraph 2 of Article 51 of the Guide.
Transient use: The device is normally intended for continuous use for less than 60 minutes.
Short-term use: The device is normally intended for continuous use for between 60 minutes and 30 days.
Long-term use: The device is normally intended for continuous use for more than 30 days.
How duration is counted is also regulated. Paragraph 6 of Article 52 of the Guide states that continuous use means the entire duration of use of the same device, without regard to temporary interruption of use during a procedure or temporary removal from use for purposes such as cleaning or disinfection. The same paragraph also treats as continuous use the total use of a device that the manufacturer intends to be replaced immediately by another device of the same type; removing the device and fitting a new one does not reset the duration.
Body Orifice, Invasive Device and Surgically Invasive Device
All the invasive device rules rest on these definitions; the difference between them is the route by which the device enters the body.
Body orifice: Any natural opening in the body, including the external surface of the eyeball, or any permanent artificial opening such as a stoma.
Invasive device: A medical device that partially or entirely penetrates, enters or is placed inside the body through a body orifice.
Surgically invasive device: An invasive device that penetrates inside the body through the surface of the body, including through mucous membranes of body orifices, in the context of or as part of a surgical operation; also a device that produces penetration other than through a body orifice.
Reusable surgical instrument: An instrument intended for surgical use in cutting, drilling, sawing, scratching, scraping, clamping, retracting, clipping or similar procedures, without a connection to an active device, and intended to be reused after appropriate procedures such as cleaning, disinfection and sterilisation have been carried out as provided by the manufacturer.
The counterpart of this definition is in Rule 6: sub-item 2 of paragraph 4(b) of Article 56 of the Guide classifies these instruments as Class I; their equivalent in ÜTS is "Class Ir".
Central Circulatory System and Central Nervous System
These definitions are the key to moving up to Class III and are given anatomically in paragraph 2 of Article 51 of the Guide.
Central circulatory system: Blood vessels including the pulmonary arteries, ascending aorta, aortic arch, descending aorta to the aortic bifurcation, coronary arteries, common carotid artery, external carotid artery, internal carotid artery, cerebral arteries, brachiocephalic trunk, cardiac veins, pulmonary veins, superior vena cava and inferior vena cava.
Central nervous system: Brain, meninges and spinal cord.
Injured skin or injured mucous membrane: An area of skin or mucous membrane that has changed following a wound, a pathological change or a disease.
Active Device, Active Therapeutic Device and Active Device for Diagnosis
The active device rules apply only to devices counted as "active", and the limit of that term lies in the definition.
Active medical device: A medical device operating by means of electrical energy or any power source, and the conversion of that energy, other than energy generated by gravity or by the human body itself.
Not counted as active: Devices intended to transmit energy, substances or other elements between a medical device and the patient without any significant change are not considered active medical devices.
Software: Software that is itself a medical device is considered an active medical device.
Active therapeutic device: Any active device used, whether alone or in combination with other devices, to support, modify, replace or restore biological functions or structures with a view to the treatment or alleviation of an illness, injury or disability.
Active device for diagnosis and monitoring (diagnostic active device): Any active device used, whether alone or in combination with other devices, to supply information for detecting, diagnosing, monitoring or treating physiological conditions, states of health, illnesses or congenital deformities.
General Rules: Accessories, Software and the Strictest Rule
Article 52 of the Guide carries the framework provisions that apply whichever rule is applied; these provisions sit above the list of rules.
Accessories are classified separately: If a device is intended to be used in combination with another device, the classification rules apply to each device separately. Accessories of a medical device are classified in their own right, separately from the device with which they are used. Paragraph 8 of Article 52 of the Guide repeats the same rule for accessories of IVD devices.
The class of software follows what it is attached to: Software which drives a device or influences the use of a device falls within the same class as the device. If the software is independent of any device, it is classified in its own right.
A device not tied to a specific part of the body: If the device is not intended to be used solely or principally in a specific part of the body, it is assessed and classified on the basis of the most critical specified use.
The strictest rule applies: If several rules, or several sub-rules within the same rule, apply to the same device based on its intended purpose, the strictest rule and sub-rule resulting in the higher classification apply.
Calibrators: Under IVDR, calibrators intended to be used with a device fall within the same class as the device.
Control materials with assigned values: Under IVDR, control materials with quantitative or qualitative assigned values for a specific analyte or multiple analytes fall within the same class as the device.
Levels of analysis: Under IVDR, each of the classification rules is applied to primary level analyses, confirmatory analyses and supportive analyses.
Annex A: The 22 MDR Classification Rules — Complete List
Paragraph 2 of Article 56 of the Guide states that devices under MDR are classified according to a total of 22 rules under the categories "Non-Invasive Devices", "Invasive Devices", "Active Devices" and "Special Rules". The distribution is 4, 4, 5 and 9 rules respectively. All 22 rules are given below, each with its own criterion and resulting class.
Non-Invasive Devices — Rules 1-4
Paragraph 3 of Article 56 of the Guide regulates the four rules in this category; the class rises as the substance contacted and the nature of the contact become more critical.
Rule 1: All non-invasive devices, unless one of the other rules in this paragraph applies → Class I
Rule 2: All non-invasive devices intended for channelling or storing blood, body liquids, cells or tissues, liquids or gases for the purpose of eventual infusion, administration or introduction into the body:
If they may be connected to a Class IIa, Class IIb or Class III active device → Class IIa
If they are intended for channelling or storing blood or other body liquids, or for storing organs, parts of organs or body cells and tissues, except blood bags → Class IIa
Blood bags → Class IIb
In all other cases → Class I
Rule 3: Consists of two sub-provisions:
All non-invasive devices intended for modifying the biological or chemical composition of human tissues or cells, blood, other body liquids or other liquids intended for implantation or administration into the body → Class IIb; however, if the treatment consists of filtration, centrifugation or exchanges of gas or heat → Class IIa
All non-invasive devices consisting of a substance or a mixture of substances intended to be used in vitro in direct contact with human cells, tissues or organs taken from the human body, or used in vitro with human embryos before their implantation or administration into the body → Class III
Rule 4: All non-invasive devices which come into contact with injured skin or injured mucous membrane:
If they are intended to be used as a mechanical barrier, for compression or for absorption of exudates → Class I
If they are intended to be used principally for injuries to the skin which have breached the dermis or mucous membrane and can heal only by secondary intent → Class IIb
If they are principally intended to manage the micro-environment of injured skin or injured mucous membrane → Class IIa
In all other cases → Class IIa
This rule also applies to invasive devices that come into contact with injured mucous membrane
Invasive Devices — Rules 5-8
Paragraph 4 of Article 56 of the Guide regulates the four rules in this category. The distinction works along three axes: how the device enters, how long it stays and where it makes contact.
Rule 5: All invasive devices with respect to body orifices, other than surgically invasive devices, which are not intended for connection to an active device or which are intended for connection to a Class I active device:
If intended for transient use → Class I
If intended for short-term use → Class IIa; however, if used in the oral cavity as far as the pharynx, in an ear canal up to the eardrum or in a nasal cavity → Class I
If intended for long-term use → Class IIb; however, if used in the same three areas and not liable to be absorbed by the mucous membrane → Class IIa
All invasive devices with respect to body orifices, other than surgically invasive devices, intended for connection to a Class IIa, Class IIb or Class III active device → Class IIa
Rule 6: All surgically invasive devices intended for transient use → Class IIa. However, if these devices:
Are intended specifically to control, diagnose, monitor or correct a defect of the heart or of the central circulatory system through direct contact with these parts of the body → Class III
Are reusable surgical instruments → Class I (Class Ir in ÜTS)
Are intended specifically for use in direct contact with the heart or central circulatory system or the central nervous system → Class III
Are intended to supply energy in the form of ionising radiation → Class IIb
Have a biological effect or are wholly or mainly absorbed → Class IIb
Are intended to administer medicinal products by means of a delivery system, if this is done in a manner that is potentially hazardous taking account of the mode of application → Class IIb
Rule 7: All surgically invasive devices intended for short-term use → Class IIa. However, if these devices:
Are intended specifically to control, diagnose, monitor or correct a defect of the heart or of the central circulatory system through direct contact with these parts of the body → Class III
Are intended specifically for use in direct contact with the heart or central circulatory system or the central nervous system → Class III
Are intended to supply energy in the form of ionising radiation → Class IIb
Have a biological effect or are wholly or mainly absorbed → Class III
Undergo chemical change in the body, except if the devices are placed in the teeth → Class IIb
Are intended to administer medicines → Class IIb
Rule 8: All implantable devices and long-term surgically invasive devices → Class IIb. However, if these devices:
Are intended to be placed in the teeth → Class IIa
Are intended to be used in direct contact with the heart, the central circulatory system or the central nervous system → Class III
Have a biological effect or are wholly or mainly absorbed → Class III
Undergo chemical change in the body, except if the devices are placed in the teeth → Class III
Are intended to administer medicinal products → Class III
Are active implantable devices or their accessories → Class III
Are breast implants or surgical meshes → Class III
Are intended for total or partial joint replacement, with the exception of ancillary components such as screws, wedges, plates and instruments → Class III
Are spinal disc replacement implants or implantable devices that come into contact with the spinal column, with the exception of components such as screws, wedges, plates and instruments → Class III
Active Devices — Rules 9-13
Paragraph 5 of Article 56 of the Guide regulates the five rules in this category. The distinction works on whether the device delivers energy, whether it is intended for diagnosis or therapy, and which decision the information it provides leads to.
Rule 9: Consists of four sub-provisions:
All active therapeutic devices intended to administer or exchange energy → Class IIa; however, if their characteristics are such that they may administer energy to or exchange energy with the human body in a potentially hazardous way, taking account of the nature, the density and the site of application of the energy → Class IIb
All active devices intended to control or monitor the performance of Class IIb active therapeutic devices, or intended directly to influence the performance of such devices → Class IIb
All active devices intended to emit ionising radiation for therapeutic purposes, including devices which control or monitor such devices, or which directly influence their performance → Class IIb
All active devices intended to control, monitor or directly influence the performance of active implantable devices → Class III
Rule 10: Active devices intended for diagnosis and monitoring:
If intended to supply energy that will be absorbed by the human body → Class IIa; however, devices intended to illuminate the patient's body in the visible spectrum → Class I
If intended to image in vivo distribution of radiopharmaceuticals → Class IIa
If intended to allow direct diagnosis or monitoring of vital physiological processes → Class IIa; however, if they are specifically intended for monitoring of vital physiological parameters, where the nature of variations is such that it could result in immediate danger to the patient, for instance variations in cardiac performance, respiration or activity of the central nervous system, or are intended for diagnosis in clinical situations where the patient is in immediate danger → Class IIb
Active devices intended to emit ionising radiation and intended for diagnostic or therapeutic radiology, including interventional radiology devices and devices which control or monitor such devices, or which directly influence their performance → Class IIb
Rule 11: Software intended to provide information which is used to take decisions with diagnostic or therapeutic purposes → Class IIa. However:
If such decisions have an impact that may cause death or an irreversible deterioration of a person's state of health → Class III
If such decisions have an impact that may cause a serious deterioration of a person's state of health or a surgical intervention → Class IIb
Software intended to monitor physiological processes → Class IIa; however, if intended for monitoring of vital physiological parameters, where variations in those parameters could result in immediate danger to the patient → Class IIb
All other software → Class I
Rule 12: All active devices intended to administer and/or remove medicinal products, body liquids or other substances to or from the body → Class IIa; however, if this is done in a manner that is potentially hazardous, taking account of the nature of the substances involved, of the part of the body concerned and of the mode of application → Class IIb
Rule 13: All other active devices → Class I
Special Rules — Rules 14-22
Paragraph 6 of Article 56 of the Guide regulates the nine rules in this category. These rules do not look at whether the device is invasive; they apply when a particular substance, technology or intended use is present, and they often raise the class that comes from the other categories.
Rule 14: All devices incorporating, as an integral part, a substance which, if used separately, can be considered to be a medicinal product as defined in point (c) of Article 4 of the Regulation on Licensing of Medicinal Products for Human Use, including a medicinal product derived from human blood or human plasma as defined in point (l) of the same article, and that has an action ancillary to that of the devices → Class III
Rule 15: All devices used for contraception or for the prevention of the transmission of sexually transmitted diseases → Class IIb; however, if they are implantable devices or long-term invasive devices → Class III
Rule 16: Consists of two sub-provisions and an exception:
All devices intended specifically to be used for disinfecting, cleaning, rinsing or, where appropriate, hydrating contact lenses → Class IIb
All devices intended specifically to be used for disinfecting or sterilising medical devices → Class IIa; however, if they are disinfecting solutions or washer-disinfectors intended specifically to be used for disinfecting invasive devices as the end point of processing → Class IIb
This rule does not apply to devices that are intended to clean devices other than contact lenses by means of physical action only
Rule 17: Devices specifically intended for recording of diagnostic images generated by X-ray radiation → Class IIa
Rule 18: All devices manufactured utilising tissues or cells of human or animal origin, or their derivatives, which are non-viable or rendered non-viable, except devices manufactured utilising non-viable or rendered non-viable tissues or cells of animal origin, or their derivatives, that are intended to come into contact with intact skin only → Class III
Rule 19: All devices incorporating or consisting of nanomaterial:
If they have a high or medium potential for internal exposure → Class III
If they have a low potential for internal exposure → Class IIb
If they have a negligible potential for internal exposure → Class IIa
Rule 20: All invasive devices with respect to body orifices, other than surgically invasive devices, intended to administer medicinal products by inhalation → Class IIa; however, if their mode of action has an essential impact on the efficacy and safety of the administered medicinal product, or if they are intended to treat life-threatening conditions → Class IIb
Rule 21: Devices that are composed of substances or of combinations of substances that are intended to be introduced into the human body via a body orifice or applied to the skin and that are absorbed by or locally dispersed in the human body:
If they, or their products of metabolism, are systemically absorbed by the human body in order to achieve the intended purpose → Class III
If they achieve their intended purpose in the stomach or lower gastrointestinal tract and they, or their products of metabolism, are systemically absorbed by the human body → Class III
If they are applied to the skin or if they are applied in the nasal or oral cavity as far as the pharynx, and achieve their intended purpose on those cavities → Class IIa
In all other cases → Class IIb
Rule 22: Active therapeutic devices with an integrated or incorporated diagnostic function which significantly determines the patient management by the device, such as closed loop systems or automated external defibrillators → Class III
Annex B: The 7 IVDR Classification Rules — Complete List
Paragraph 2 of Article 57 of the Guide states that devices under IVDR are classified according to a total of 7 classification rules. Unlike MDR, there are no categories here; the rules run from the highest risk to the lowest, and the last two rules collect the remaining devices. All seven rules are given below.
Rule 1 (Class D): Devices intended to be used for the following purposes → Class D:
Detecting the presence of, or exposure to, a transmissible agent in blood, blood components, cells, tissues or organs, or in any of their derivatives, in order to assess their suitability for transfusion, transplantation or cell administration
Detecting the presence of, or exposure to, a transmissible agent that causes a life-threatening disease with a high or suspected high risk of propagation
Determining the infectious load of a life-threatening disease where monitoring is critical in the process of patient management
Rule 2: Devices intended to be used for blood grouping, or to determine fetomaternal blood group incompatibility, or for tissue typing in order to ensure the immunological compatibility of blood, blood components, cells, tissue or organs that are intended for transfusion or transplantation or cell administration → Class C. However, if they are intended to determine any of the following markers → Class D:
ABO system [A (ABO1), B (ABO2), AB (ABO3)]
Rhesus system [RH1 (D), RHW1, RH2 (C), RH3 (E), RH4 (c), RH5 (e)]
Kell system [Kel1 (K)]
Kidd system [JK1 (Jka), JK2 (Jkb)]
Duffy system [FY1 (Fya), FY2 (Fyb)]
Rule 3 (Class C): Devices used for the following thirteen purposes → Class C:
Detecting the presence of, or exposure to, a sexually transmitted agent
Detecting the presence in cerebrospinal fluid or blood of an infectious agent without a high or suspected high risk of propagation
Detecting the presence of an infectious agent where there is a significant risk that an erroneous result would cause death or severe disability to the individual, fetus or embryo being tested, or to the individual's offspring
Pre-natal screening of women in order to determine their immune status towards transmissible agents
Determining infective disease status or immune status where there is a risk that an erroneous result would lead to a patient management decision resulting in a life-threatening situation for the patient or for the patient's offspring
Being used as companion diagnostics
Being used for disease staging where there is a risk that an erroneous result would lead to a patient management decision resulting in a life-threatening situation for the patient or for the patient's offspring
Being used in screening, diagnosis or staging of cancer
Human genetic testing
Monitoring of levels of medicinal products, substances or biological components, where there is a risk that an erroneous result would lead to a patient management decision resulting in a life-threatening situation for the patient or for the patient's offspring
Management of patients suffering from a life-threatening disease or condition
Screening for congenital disorders in the embryo or fetus
Screening for congenital disorders in new-born babies where failure to detect and treat such disorders could lead to life-threatening situations or severe disabilities
Rule 4: Consists of two sub-provisions:
Devices intended for self-testing → Class C; however, devices intended for the detection of pregnancy, for fertility testing and for determining cholesterol level, and devices for the detection of glucose, erythrocytes, leucocytes and bacteria in urine → Class B
Devices intended for near-patient testing are classified in their own right
Rule 5 (Class A): The following devices → Class A:
Products for general laboratory use, accessories which possess no critical characteristics, buffer solutions, washing solutions, and general culture media and histological stains, intended by the manufacturer to make them suitable for in vitro diagnostic procedures relating to a specific examination
Instruments intended by the manufacturer specifically to be used for in vitro diagnostic procedures
Specimen receptacles
Rule 6: All other in vitro diagnostic devices → Class B
Rule 7: Controls without a quantitative or qualitative assigned value → Class B
Rule 7 must be read together with paragraph 10 of Article 52 of the Guide: control materials with assigned values fall within the same class as the device, while controls without an assigned value are directly Class B.
The 18 MDD Rules and Differences from MDR
For devices remaining on the market under the former regulation, classification is still made according to the MDD rules. Paragraph 2 of Article 53 of the Guide states that devices under MDD are classified according to a total of 18 rules under the categories "Non-Invasive Devices", "Invasive Devices", "Active Devices" and "Special Rules". The distribution is 4, 4, 4 and 6 rules; in MDR, active devices rose to 5 rules and special rules to 9.
Blood bags: The MDD has a separate rule for this: Rule 18 in paragraph 6 of Article 53 of the Guide, unlike the other rules, classifies blood bags as Class IIb. In MDR this provision is not a separate rule; it has been moved into the third sub-item of Rule 2 in paragraph 3(b) of Article 56.
Four newly added rules: There is no equivalent in the MDD for MDR Rule 19 (nanomaterial), Rule 20 (devices administering medicinal products by inhalation), Rule 21 (devices based on absorbed or locally dispersed substances) and Rule 22 (closed loop systems and automated external defibrillators).
Widening of Rule 8: Among the implants that fall into Class III under MDD Rule 8 are breast implants and shoulder, knee and hip joint replacement devices. In MDR Rule 8 this list is widened: surgical meshes are added next to breast implants, the joint side is generalised as "total or partial joint replacement", and spinal disc replacement implants and implantable devices that come into contact with the spinal column are also placed in Class III. In both provisions, components such as screws, wedges, plates and instruments are left outside the scope.
How Classification Works under AIMDD and IVDD
In these two frameworks there is no device-specific list of rules; classification is derived from the conformity assessment procedures applied. Paragraph 1 of Article 54 of the Guide states that there is no classification rule specific to devices under AIMDD and that, taking into account the conformity assessment procedures carried out for the relevant devices and referred to in Article 59 of the Guide, these devices are treated as belonging to the class equivalent to the highest risk class under MDD (Class III). Paragraph 2 states that, accordingly, devices under AIMDD are also classified as Class III in ÜTS.
On the IVDD side, paragraph 1 of Article 55 of the Guide states that there is no device-specific classification rule, and that additional provisions apply to the high-risk IVD devices listed in IVDD Annex II and to self-testing devices other than those in Annex II. Paragraph 3 states that devices under IVDD are classified in ÜTS as "Annex II List A", "Annex II List B", "Self-Testing Devices" and "IVD Other".
IVDD Annex II List A and List B Items
Paragraph 2 of Article 55 of the Guide lists the high-risk IVD devices in IVDD Annex II in two lists; if your device falls into one of these lists, its class in ÜTS is determined.
List A (Annex II List A): Reagents and reagent products, including related calibrators and control materials, for determining the following blood groups: ABO system, Rhesus (C, c, D, E, e), anti-Kell; reagents and reagent products, including related calibrators and control materials, for the detection, confirmation and quantification in human specimens of markers of HIV infection (HIV 1 and 2), HTLV I and II, and hepatitis B, C and D.
List B (Annex II List B): Reagents and reagent products for determining the following blood groups: anti-Duffy and anti-Kidd; for determining irregular anti-erythrocytic antibodies; for the detection and quantification in human samples of the following congenital infections: rubella and toxoplasmosis; for the diagnosis of the following hereditary disease: phenylketonuria; for determining the following human infections: cytomegalovirus and chlamydia; for determining the following HLA tissue groups: DR, A, B; for determining the following tumoral marker: PSA; for evaluating the risk of trisomy 21, including software, reagents, reagent products, calibrators and control materials specifically designed for this purpose; and the device for self-diagnosis, including its related calibrators and control materials: blood sugar measurement.
Applying the Rules: Product Group Examples
Listing the rules does not determine the class; what is critical is which rule captures which product group.
Wound dressings and bandages: Assessed under Rule 4. If the product is only a mechanical barrier for absorbing exudates, it is Class I; if it is used for skin injuries that have breached the dermis and heal by secondary intent, Class IIb; if it is intended to manage the micro-environment, and in all other cases, Class IIa.
Catheters: The decision is made between Rule 5 and Rule 8. Three questions are decisive: whether the device enters through a body orifice or surgically, whether the duration of use is transient, short-term or long-term, and whether its tip contacts the heart, the central circulatory system or the central nervous system.
Contact lens solutions: They are covered by the first sub-item of Rule 16 and are Class IIb. The exception in the last sentence of the same rule, "cleaning by physical action only", does not apply to these products because contact lenses are expressly excluded from it.
Dental fillings, brackets and crowns: There are two separate exceptions for devices placed in the teeth. The fifth sub-item of Rule 7 excludes devices placed in the teeth from the provision on undergoing chemical change in the body. The first sub-item of Rule 8 moves implantable devices intended to be placed in the teeth from Class IIb to Class IIa.
ÜTS Sub-Classes Are Not the Same as the Classes in the Regulation
The class list you see in ÜTS is longer than the four classes in the regulation, and this is not a contradiction. Paragraph 1 of Article 56 of the Guide explains in parentheses that additional classifications have been made in ÜTS according to characteristic product features, such as whether the device is packaged sterile or has a measuring function. The same paragraph also gives an example: a device that is "Class Ir" in ÜTS and a device that is "Class I Other" in ÜTS are both Class I under MDR.
The same structure is set up on the IVDR side. Paragraph 1 of Article 57 of the Guide states that additional classifications have been made in ÜTS according to characteristic product features and intended purposes, such as whether the device is packaged sterile or is a companion diagnostic device, and gives as an example that a device that is a "Near-Patient Testing Device (Class C)" in ÜTS is classified as Class C under IVDR. In practice, this means that marking sterility or the measuring function wrongly, even if it does not change the regulatory class, leads in ÜTS to the wrong sub-class and therefore the wrong document business rule.
Who Decides in a Classification Dispute?
A dispute may arise between a notified body and the manufacturer over class; the way to resolve it is set out in the regulation. Paragraph 2(a) of Article 51 of the Medical Device Regulation states that disputes between the notified bodies concerned and a manufacturer established in Türkiye, arising from the application of Annex VIII, will be referred to the Agency for a decision. The same subparagraph states that disputes between a manufacturer established in the EU and a notified body established in Türkiye are referred to the competent authority of the EU member state in which the manufacturer has its registered place of business.
Subparagraph (b) of the same paragraph regulates cases where the manufacturer has no registered place of business in Türkiye or in EU member states and has not yet appointed an authorised representative. Subparagraph (c) states that, where the notified body concerned is located abroad, the Agency will give its decision after consultation with the competent authority of the country that designated the notified body, and will notify its decision to the MDCG and the Commission.
Decision Trees: Annex Charts of the Guide
The Guide supports the written text of the rules with decision tree charts. The references in parentheses at the end of each rule show which chart to consult.
MDR rules: The references in paragraphs 3 to 6 of Article 56 of the Guide point to the charts in Annex 31 to Annex 42. For example, Annex 31 is shown for Rules 1, 2 and 4, Annex 32 for Rule 3, Annex 33 for Rule 5, Annex 36 for Rule 8, Annex 40 for Rule 11, and Annex 41 and Annex 42 for the special rules.
IVDR rules: The references in paragraph 2 of Article 57 of the Guide point to the charts in Annex 43 to Annex 47. Annex 44 is shown for Rule 1, Annex 45 for Rule 2, Annex 46 for Rule 3, Annex 47 for Rules 4 and 5, and Annex 43 for Rules 6 and 7.
MDD rules: The references in Article 53 of the Guide point to the charts in Annex 23 to Annex 30. Annex 23 is shown for non-invasive devices, Annex 24 for Rule 5, Annex 27 for Rule 8, Annex 28 and Annex 29 for active devices, and Annex 30 for special rules.
The class decision is one of the hardest areas to correct afterwards: paragraph 7 of Article 43 of the Guide states that data change requests concerning the "Class" field are in every case submitted to the Agency's approval. For this reason, the class should be determined before the registration is opened, by reading the intended purpose statement, the certificate scope and the technical file together.
Companies can also carry out this assessment by opening a user authorisation for a consultant from their own ÜTS company page; with the "Medical Device Registration Officer" authorisation the consultant creates the records, while the person who signs the application remains the company's authorised signatory.
For the place of the same subject in EU legislation, you can find it in our English article titled MDR classification rules.
